Competitive Drug Development International (CDDI)
Research Services • 
London, England, United Kingdom • 1-10 Employees
Company overview
| Headquarters | London, England, United Kingdom |
| Website | |
| NAICS | 5417 |
| SIC | 283 |
| Keywords | Clinical Development, Consulting And Operational Support, Evidence-Based Protocol Feasibility (Ebf) |
| Founded | 2009 |
| Employees | 1-10 |
| Socials |
Key Contact at Competitive Drug Development International (CDDI)
Grahaem Brown
Founder
Competitive Drug Development International (CDDI) Email Formats
Competitive Drug Development International (CDDI) uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@cddi.co), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@cddi.co | 100% |
About Competitive Drug Development International (CDDI)
CDDI is a specialist bio-medical consulting company based in London and Barcelona and founded in 2009 by R&D executives from top Pharma companies. We have extensive experience of clinical development and operations across a broad range of indications. We work with clients to ensure their development plans and protocols are feasible, and to improve patient accrual. Our current focus includes: - Evidence-based Feasibility for Big Pharma and Biotechs - Protocol feasibility, Paediatric Investigational Plans (PIPs), root cause analyses for failing protocols - Site selection - Patient recruitment strategies - Process reengineering/optimization for Big Pharma and Biotechs Our other capabilities include: - Project management for Biotechs - Design and execution of Phase 1 protocols - Design protocols, site selection and manage CROs for Phase 2 protocols What is Evidence-based Feasibiliy? Evidence-based Feasibility (EbF) involves collecting real — but de-identified — data from retrospective patient records from sites that could be around the globe. Our company specific process, EbF, can show the effect of each inclusion/exclusion criterion on potential patient recruitment, allowing us to simulate alternative scenarios. This enables the client, in consultation with the experts in the field, to decide the final study protocol, finding a balance between “perfect” criteria and what is scientifically sound and yet still operationally feasible. EbF contributes to establishing a protocol: - requiring no unnecessary amendments; - with recruitment projections based on facts, not perceptions; - using the optimal number of sites. The EbF process saves overall time and resource, making it possible to carry out more effective clinical trials.
Competitive Drug Development International (CDDI) revenue & valuation
| Annual revenue | $427,775 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Research Services industry and current estimated revenues | $1,400,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Competitive Drug Development International (CDDI) has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Competitive Drug Development International (CDDI) has never raised funding before.
Competitive Drug Development International (CDDI) Tech Stack
Discover the technologies and tools that power Competitive Drug Development International (CDDI)'s digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Issue trackers
Appointment scheduling
PaaS
Blogs
Miscellaneous
Programming languages
Miscellaneous
Security
JavaScript frameworks
Blogs
IaaS
Spain
United States
Frequently asked questions
4.8
40,000 users
